Aroa Biosurgery in trading halt for capital raise

Aroa Biosurgery in trading halt for capital raise
Aroa has five products approved for sale in the US. (Image: Supplied)
Rebecca Stevenson
New Zealand headquartered medical company Aroa will raise capital to boost its presence in the US.The Australian Financial Review reported the company was seeking A$52 million to fund the expansion of its US sales team, as well as research and development.In a June market update, the soft-tissue regeneration company said US medical procedure numbers continued to reflect a positive trend “supporting improved sales momentum”.Aroa has commercial operations based in San Diego and sales professionals across the US. In its 2021 results fo...

More Markets

NZ sharemarket down 1.13% for the week
Markets Market close

NZ sharemarket down 1.13% for the week

The S&P/NZX 50 Index closed at 11,796.21, down 39.83 points or 0.34%.

Graham Skellern 19 Apr 2024
Bell Potter boosts Santana target price 53.5%
Primary Sector

Bell Potter boosts Santana target price 53.5%

Aussie brokers increasingly like the look of a low-cost, high yield Otago gold play.

Pattrick Smellie 19 Apr 2024
Anna Palairet appointed Fonterra's chief operating officer
Primary Sector

Anna Palairet appointed Fonterra's chief operating officer

Having acted in the role since June last year, she replaces Fraser Whineray.

Riley Kennedy 19 Apr 2024
Analysts upbeat about Tower's latest guidance
Markets

Analysts upbeat about Tower's latest guidance

The insurer's shares have gained 36% so far this year. 

Rebecca Howard 19 Apr 2024